Skip to main content
Fig. 3 | Trials

Fig. 3

From: Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial

Fig. 3

Participant flow chart to determine antimalarial treatment regimen under fMDA-DHAp. Women of reproductive age (WRA): those 15 to 49-years-old; RDT: rapid diagnostic test; HF: health facility; MDA: mass drug administration; DHAp: dihydroartemisinin plus piperaquine

Back to article page